We’re building frontier AI to

Explore our platform

Our team has built one of the largest collections of multimodal tumor data that exists anywhere on Earth, and we’ve used it to train foundation models capable of representing, and simulating, the full complexity of a tumor microenvironment. Now we’re going to use it to change the way cancer treatment is done.

Creating clinical trials that are enriched for likely responders.

Nearly all cancer clinical trials enroll patients based on coarse biomarkers that don’t actually predict response. We believe our models can identify responders far more accurately.

Case Study

Positioning clinical-stage drugs in the right patients.

95% percent of cancer drugs fail their clinical trials. We believe a significant fraction of those drugs actually work on the right patient population.

Case Study

Discovering new cancer targets that translate to humans.

The oncology field has focused on the same set of a dozen cancer targets for decades. We believe our platform is capable of discovering hundreds more.

Case Study

Proud to be backed by leading investors

Research